What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/41994 |
Resumo: | Artigo encontra-se em acesso aberto por causa da pandemia mundial do COVID-19. |
id |
CRUZ_922970c2cc6187c7a9a795993eff003e |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/41994 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Guterres, AlexandroLima, Carlos Henrique de AzeredoMiranda, Renan LyraGadelha, Mônica Roberto2020-06-30T14:18:05Z2020-06-30T14:18:05Z2020GUTERRES, Alexandro et al. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infection, Genetics and Evolution, v. 85, 104417, p. 1-3, June 2020.1567-1348https://www.arca.fiocruz.br/handle/icict/4199410.1016/j.meegid.2020.1044171567-7257Artigo encontra-se em acesso aberto por causa da pandemia mundial do COVID-19.Instituto Estadual do Cérebro. Laboratório de Neuropatologia e Genética Molecular. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hantaviroses e Rickettsioses. Rio de Janeiro, RJ, Brasil.Instituto Estadual do Cérebro. Laboratório de Neuropatologia e Genética Molecular. Rio de Janeiro, RJ, Brasil.Instituto Estadual do Cérebro. Laboratório de Neuropatologia e Genética Molecular. Rio de Janeiro, RJ, Brasil.Instituto Estadual do Cérebro. Laboratório de Neuropatologia e Genética Molecular. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Escola de Medicina. Centro de Pesquisa em Neuroendocrinologia. Divisão de Endocrinologia. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Hospital Universitário Clementino Fraga Filho. Rio de Janeiro, RJ, Brasil.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19, a pandemic associated with substantial morbidity and mortality. Despite of this, no vaccine or approved drug is available to eradicate the virus. In this manuscript, we present an alternative study area that may contribute to development of diagnostic biomarkers and therapeutic targets for COVID-19. We analyzed sixty SARS-CoV-2 genomes to identify regions that could work as virus-encoded miRNA seed sponges and potentially bind to human miRNA seed sites and prevent interaction with their native targets thereby relieving native miRNA suppression. MicroRNAs (miRNAs) are evolutionally conserved single-stranded RNAs that regulate gene expression at the posttranscriptional level by disrupting translation. MiRNAs are key players in variety of biological processes that regulate differentiation, development and activation of immune cells in both innate and adaptive immunity. We find 34 miRNAs for positive-sense viral RNA and 45 miRNAs for negative-sense that can strongly bind to certain key SARS-CoV-2 genes. The disruption and dysfunction of miRNAs may perturb the immune response and stimulate the release of inflammatory cytokines altering the cellular response to viral infection. Previous studies demonstrate that miRNAs have the potential to be used as diagnostic and therapeutic biomarkers. Therefore, its discovery and validation are essential for improving the diagnosis of infection and clinical monitoring in COVID-19.engElsevierSARS-CoV-2COVID-19microRNABiomarcadoresAlvos terapêuticosSARS-CoV-2COVID-19microRNABiomarkersTherapeutic targetsWhat is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/41994/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALGuterres_Alexandro_etal_IOC_2020_COVID-19.pdfGuterres_Alexandro_etal_IOC_2020_COVID-19.pdfapplication/pdf470849https://www.arca.fiocruz.br/bitstream/icict/41994/2/Guterres_Alexandro_etal_IOC_2020_COVID-19.pdfb08e7230db2fa1d5b36cad9486bcdd9aMD52TEXTGuterres_Alexandro_etal_IOC_2020_COVID-19.pdf.txtGuterres_Alexandro_etal_IOC_2020_COVID-19.pdf.txtExtracted texttext/plain19281https://www.arca.fiocruz.br/bitstream/icict/41994/3/Guterres_Alexandro_etal_IOC_2020_COVID-19.pdf.txt0e536334bef2b67457574f494a7e01f0MD53icict/419942020-07-01 02:03:41.282oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-07-01T05:03:41Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
title |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
spellingShingle |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Guterres, Alexandro SARS-CoV-2 COVID-19 microRNA Biomarcadores Alvos terapêuticos SARS-CoV-2 COVID-19 microRNA Biomarkers Therapeutic targets |
title_short |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
title_full |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
title_fullStr |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
title_full_unstemmed |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
title_sort |
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? |
author |
Guterres, Alexandro |
author_facet |
Guterres, Alexandro Lima, Carlos Henrique de Azeredo Miranda, Renan Lyra Gadelha, Mônica Roberto |
author_role |
author |
author2 |
Lima, Carlos Henrique de Azeredo Miranda, Renan Lyra Gadelha, Mônica Roberto |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Guterres, Alexandro Lima, Carlos Henrique de Azeredo Miranda, Renan Lyra Gadelha, Mônica Roberto |
dc.subject.other.pt_BR.fl_str_mv |
SARS-CoV-2 COVID-19 microRNA Biomarcadores Alvos terapêuticos |
topic |
SARS-CoV-2 COVID-19 microRNA Biomarcadores Alvos terapêuticos SARS-CoV-2 COVID-19 microRNA Biomarkers Therapeutic targets |
dc.subject.en.pt_BR.fl_str_mv |
SARS-CoV-2 COVID-19 microRNA Biomarkers Therapeutic targets |
description |
Artigo encontra-se em acesso aberto por causa da pandemia mundial do COVID-19. |
publishDate |
2020 |
dc.date.accessioned.fl_str_mv |
2020-06-30T14:18:05Z |
dc.date.available.fl_str_mv |
2020-06-30T14:18:05Z |
dc.date.issued.fl_str_mv |
2020 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GUTERRES, Alexandro et al. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infection, Genetics and Evolution, v. 85, 104417, p. 1-3, June 2020. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/41994 |
dc.identifier.issn.pt_BR.fl_str_mv |
1567-1348 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.meegid.2020.104417 |
dc.identifier.eissn.none.fl_str_mv |
1567-7257 |
identifier_str_mv |
GUTERRES, Alexandro et al. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infection, Genetics and Evolution, v. 85, 104417, p. 1-3, June 2020. 1567-1348 10.1016/j.meegid.2020.104417 1567-7257 |
url |
https://www.arca.fiocruz.br/handle/icict/41994 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/41994/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/41994/2/Guterres_Alexandro_etal_IOC_2020_COVID-19.pdf https://www.arca.fiocruz.br/bitstream/icict/41994/3/Guterres_Alexandro_etal_IOC_2020_COVID-19.pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 b08e7230db2fa1d5b36cad9486bcdd9a 0e536334bef2b67457574f494a7e01f0 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324984893931520 |